Feeding Behavior and Taste Sensitivity Before and After Liver or Renal Transplantation
NCT ID: NCT02931812
Last Updated: 2019-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2014-05-31
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pre-emptive Kidney Transplantation Quality of Life
NCT02154815
Evolution and Clinical Outcomes in Patients Undergoing Liver Transplantation
NCT02917382
Establishment of a Personalized Pharmaceutical Plan in Renal or Hepatic Transplant Patients
NCT04295928
Calorimetry, Insulin Resistance and Energy Metabolism Study to Understand the Risk of Obesity in Kidney Transplanted Patients
NCT01800851
A Randomized Trial to Reduce the Disparity in Live Donor Kidney Transplantation
NCT00785265
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Fifteen end-stage cirrhotic patients and 15 renal failure patients will be included and matched with 30 healthy subjects. The following parameters will be evaluated during a morning testing session: gustatory sensitivity using a triangular detection threshold method for sweet, salty and umami solutions; preferences for fat- and carbohydrate-rich foods using the PrefQuest score; liking for six foods (protein-, carbohydrate- and fat-rich foods) and wanting for 18 foods (photographs); hunger sensation; energy intake (24 h ingested food); body composition (BMI and impedancemetry); resting energy expenditure (indirect calorimetry) and physical activity (questionnaire). Several plasmatic parameters (amino-acids, leptin, ghrelin, lipid profile) will be also determined.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cirrhotic subjects
15 cirrhotic patients in end-stage in waiting a graft
No interventions assigned to this group
Chronic kidney disease subjects
15 chronic kidney disease patients in end-stage in waiting a graft
No interventions assigned to this group
Healthy subjects
30 healthy subjects to compare
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients in waiting renal transplant
* patients in waiting liver transplant
Exclusion Criteria
* acute infection
* cancer
* antibiotic treatments
* alcool abuse
* pregnant woman
* specific or restrictive diet
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Burgundy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Laurent BRONDEL
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Taste and Feeding Behaviour
Dijon, Burgundy, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-A00254-43
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.